Year: 2020

News

PARTNER RELEASE: Esperion Announces Commercial Availability of the NEXLETOL™ (bempedoic acid) Tablet

ANN ARBOR, Mich., March 30, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced today that NEXLETOL™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering medicine is now available…

PARTNER RELEASE: FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s FARXIGA (dapagliflozin) reduced the incidence of the…

Coronavirus: A Message From ABC President Michelle A. Albert, MD, MPH

Coronavirus: A Message From ABC President Michelle A. Albert, MD, MPH Dear Friends and Colleagues, At this time in our global history, we are severely challenged by the ongoing COVID-19/coronavirus…

Partner Release: Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine

– First Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine Approved in the U.S. in Nearly 20 Years for Indicated Patients – – NEXLETOL Lowers LDL-Cholesterol with a First-in-Class Mechanism – – Fills an Unmet…

News Release: ABC Endorses Black Maternal Health Momnibus

WASHINGTON D.C. — The Association of Black Cardiologists (ABC) is pleased to support the Black Maternal Health Momnibus – composed of nine individual bills and introduced by Congresswoman Lauren Underwood,…

News Release: National Partnership Forms to Take Bold Steps in Hypertension Control

     Washington, DC, February 28, 2020 – As part of its mission to promote the prevention and treatment of cardiovascular disease, including stroke, in Blacks and other minorities, the…